China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
1.110
-0.190 (-14.62%)
Jul 31, 2026, 4:00 PM EDT - Market closed

China Pharma Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.994.144.537.018.19.64
Revenue Growth
-7.07%-8.49%-35.41%-13.48%-15.95%-11.27%
Gross Profit
0.29-0.13-1.99-0.28-0.490.35
Operating Income
-3.6-3.24-4.59-2.75-3.55-2.86
Net Income
-3.55-3.19-4.74-3.08-3.97-3.4
Earnings Per Share
-0.54-0.74-2.71-9.10-37.80-37.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.170.350.651.492.044.95
Total Debt
3.563.63.594.638.7612.49
Net Cash (Debt)
-3.39-3.25-2.95-3.14-6.71-7.54
Net Cash Growth
------
Net Cash Per Share
-0.34-0.76-1.69-9.29-63.85-81.70

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.150.15-0.41-0.7-0.41-0.25
Capital Expenditures
-0-0.06-0.04-0.01-0.4-0.44
Free Cash Flow
0.150.09-0.44-0.71-0.81-0.69
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.26%-3.18%-43.84%-4.01%-6.09%3.62%
Operating Margin
-90.13%-78.16%-101.32%-39.25%-43.79%-29.67%
Pretax Margin
-88.82%-76.91%-104.58%-43.91%-49.02%-35.26%
Profit Margin
-88.82%-76.91%-104.58%-43.91%-49.02%-35.26%
FCF Margin
3.75%2.15%-9.81%-10.14%-10.01%-7.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
271.54211.18----
PS Ratio
11.274.531.680.920.892.37